4.3 Article

Several serum lipid metabolites are associated with relapse risk in pediatric-onset multiple sclerosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials

Maija Dambrova et al.

Summary: Acylcarnitines are fatty acid metabolites that play important roles in cellular energy metabolism and have potential as biomarkers and pharmaceutical agents for various diseases. This comprehensive review provides detailed information on the identity, nomenclature, classification, biochemistry, pathophysiology, and clinical trials of acylcarnitines. It also discusses their use as dietary supplements and the emerging opportunities for using them as biomarkers and interventions in different indications. The review lays a solid foundation for further understanding the physiological roles of acylcarnitines and the identification of new drug targets.

PHARMACOLOGICAL REVIEWS (2022)

Article Medicine, General & Internal

Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis

Kathryn C. Fitzgerald et al.

Summary: In people with multiple sclerosis, an intermittent calorie restriction diet is associated with reduction in memory T cell subsets and changes in certain lipid markers.

EBIOMEDICINE (2022)

Article Biochemistry & Molecular Biology

Serum phospholipidomics reveals altered lipid profile and promising biomarkers in multiple sclerosis

Helena Beatriz Ferreira et al.

Summary: Multiple sclerosis is a neurodegenerative disease that causes disability in young adults, and has been associated with alterations in metabolism and lipid profile. This study reveals a distinctive lipid signature of multiple sclerosis, particularly in certain phospholipid species, and suggests that specific phospholipids may serve as potential biomarkers for clinical applications in multiple sclerosis.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)

Article Clinical Neurology

Serum ceramide levels are altered in multiple sclerosis

Angeliki G. Filippatou et al.

Summary: Ceramide levels are altered in people with multiple sclerosis, with specific types of ceramides being associated with disease progression and neurodegeneration in the brain.

MULTIPLE SCLEROSIS JOURNAL (2021)

Review Biochemistry & Molecular Biology

L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine

Marc R. McCann et al.

Summary: The modern advancements in metabolomics have enabled the discovery of new metabolite biomarkers, with potential clinical applications of L-carnitine and acylcarnitines being explored.

METABOLITES (2021)

Article Biochemistry & Molecular Biology

Medium & long-chain acylcarnitine's relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: a metabolomic study

Dan-meng Zheng et al.

Summary: This study found that medium and long-chain acylcarnitines, especially C14, are closely related to the risk of DCM. Exogenous C14 supplementation led to lipid accumulation in cardiomyocytes, impacting fatty acid oxidation and ultimately causing myocardial lipotoxicity, hypertrophy, fibrosis, and apoptosis, which could be alleviated by the AMPK agonist acadesine.

LIPIDS IN HEALTH AND DISEASE (2021)

Review Physiology

Plasmalogens and Chronic Inflammatory Diseases

Jose Carlos Bozelli et al.

Summary: Lipids play key roles in cellular function, with plasmalogens receiving attention due to their association with degenerative and metabolic disorders. Inflammatory processes can affect plasmalogen levels and trigger either anti- or pro-inflammatory responses. Restoring plasmalogen levels has been shown to be a successful anti-inflammatory strategy.

FRONTIERS IN PHYSIOLOGY (2021)

Review Endocrinology & Metabolism

Disrupted Lipid Metabolism in Multiple Sclerosis: A Role for Liver X Receptors?

Ines Pineda-Torra et al.

Summary: Multiple sclerosis (MS) is a chronic neurological disease characterized by disrupted lipid metabolism and involvement of liver X receptors (LXRs) in immune responses. Current research is focused on targeting these receptors for therapeutic potential in metabolic and inflammatory diseases, including MS, and exploring important areas for future research.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Cell Biology

Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism

Kathryn C. Fitzgerald et al.

Summary: The study explored the pathophysiology of multiple sclerosis (MS) through the circulating metabolome, revealing abnormalities in aromatic amino acid (AAA) metabolism in PwMS that are associated with disability. Additionally, analysis of scRNA-seq data indicated altered AAA metabolism in PwMS.

CELL REPORTS MEDICINE (2021)

Article Clinical Neurology

Metabolomics in multiple sclerosis disease course and progression

Pavan Bhargava et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Article Medicine, Research & Experimental

Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation

Pavan Bhargava et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Clinical Neurology

Plasma lipidomics of monozygotic twins discordant for multiple sclerosis

Horst Penkert et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)

Review Physiology

MYELIN IN THE CENTRAL NERVOUS SYSTEM: STRUCTURE, FUNCTION, AND PATHOLOGY

Christine Stadelmann et al.

PHYSIOLOGICAL REVIEWS (2019)

Article Clinical Neurology

Metabolome-based signature of disease pathology in MS

S. L. Andersen et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)

Article Multidisciplinary Sciences

Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis

L. Nogueras et al.

SCIENTIFIC REPORTS (2019)

Article Clinical Neurology

Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis

Saeedeh Azary et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Review Cell Biology

Sphingolipids and their metabolism in physiology and disease

Yusuf A. Hannun et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Review Medicine, General & Internal

Multiple Sclerosis

Daniel S. Reich et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Medicine, Research & Experimental

The relevance of ceramides and their synthesizing enzymes for multiple sclerosis

Jennifer Kurz et al.

CLINICAL SCIENCE (2018)

Article Clinical Neurology

Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course

Bardia Nourbakhsh et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)

Article Endocrinology & Metabolism

Acylcarnitines activate proinflammatory signaling pathways

Jennifer M. Rutkowsky et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)

Review Neurosciences

Polyunsaturated fatty acids and their metabolites in brain function and disease

Richard P. Bazinet et al.

NATURE REVIEWS NEUROSCIENCE (2014)

Article Biochemical Research Methods

The sva package for removing batch effects and other unwanted variation in high-throughput experiments

Jeffrey T. Leek et al.

BIOINFORMATICS (2012)

Article Clinical Neurology

Aberrant Upregulation of Astroglial Ceramide Potentiates Oligodendrocyte Injury

SunJa Kim et al.

BRAIN PATHOLOGY (2012)

Article Biochemistry & Molecular Biology

Plasmalogens the neglected regulatory and scavenging lipid species

Stefan Wallner et al.

CHEMISTRY AND PHYSICS OF LIPIDS (2011)

Article Biochemical Research Methods

WGCNA: an R package for weighted correlation network analysis

Peter Langfelder et al.

BMC BIOINFORMATICS (2008)

Review Gastroenterology & Hepatology

Oxidative stress: A radical way to stop making bile

Marcelo G. Roma et al.

ANNALS OF HEPATOLOGY (2008)

Review Biochemistry & Molecular Biology

Modulation of inflammation in brain: a matter of fat

Akhlaq A. Farooqui et al.

JOURNAL OF NEUROCHEMISTRY (2007)

Article Multidisciplinary Sciences

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

A Subramanian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)